<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35600275</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">8755-1225</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>38</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians</Title>
          <ISOAbbreviation>J Pharm Technol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Safety and Efficacy of Indomethacin for Reducing Chest Tube Duration After Coronary Artery Bypass Grafting Surgery.</ArticleTitle>
        <Pagination>
          <StartPage>148</StartPage>
          <EndPage>154</EndPage>
          <MedlinePgn>148-154</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/87551225221074588</ELocationID>
        <Abstract>
          <AbstractText><b>Background:</b> Nonsteroidal anti-inflammatory drugs (NSAIDs) contain a boxed warning for use in coronary artery bypass graft (CABG) surgery due to increased risk of thrombotic events, but recent research has challenged the assumption that these risks are a class effect. One anecdotal indication for NSAIDs in CABG is reducing chest tube output. <b>Objective:</b> The primary objective of this retrospective study was to determine whether indomethacin was associated with reduced duration of chest tube insertion after CABG surgery, defined as total chest tube duration in controls versus duration of chest tube insertion after the first dose of indomethacin in the treatment group. Secondary objectives were comparisons of daily reductions in chest tube output volume, length of stay, and safety between groups. <b>Methods:</b> In this retrospective, single-center case-control review, adult patients who received indomethacin after CABG were matched 1:1 to control patients based on age, sex, concomitant valve surgery, and, when possible, diabetes status. <b>Results:</b> Thirty-two patients were included. The mean age was 56 years and 75% were men. The primary outcome measure was 94 hours among control patients and 82.8 hours among indomethacin patients (<i>P</i> = 0.041). Insignificant mean reductions in daily chest tube output were observed prior to and after indomethacin initiation (38.7 vs 87.7 mL/day, <i>P</i> &gt; 0.05). <b>Conclusion:</b> In this small, single-center study, indomethacin appeared safe and possibly effective for reducing chest tube duration after CABG surgery. Future large, prospective, randomized studies should be conducted to confirm the results.</AbstractText>
          <CopyrightInformation>Â© The Author(s) 2022.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gibson</LastName>
            <ForeName>Caitlin M</ForeName>
            <Initials>CM</Initials>
            <Identifier Source="ORCID">0000-0002-9750-4621</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacotherapy, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hall</LastName>
            <ForeName>Brenton</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, JPS Health Network, Fort Worth, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kwon</LastName>
            <ForeName>Hyanggi Irene</ForeName>
            <Initials>HI</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Medical City Arlington, Arlington, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Davis</LastName>
            <ForeName>Sondra</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacy, Medical City Arlington, Arlington, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bradford</LastName>
            <ForeName>Darien</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgery, Medical City Arlington, Arlington, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Howard</LastName>
            <ForeName>Meredith L</ForeName>
            <Initials>ML</Initials>
            <Identifier Source="ORCID">0000-0003-4514-3948</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacotherapy, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Pharm Technol</MedlineTA>
        <NlmUniqueID>8504643</NlmUniqueID>
        <ISSNLinking>1549-4810</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">anti-inflammatory agents</Keyword>
        <Keyword MajorTopicYN="N">chest tubes</Keyword>
        <Keyword MajorTopicYN="N">coronary artery bypass</Keyword>
        <Keyword MajorTopicYN="N">indomethacin</Keyword>
        <Keyword MajorTopicYN="N">nonsteroidal</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>1</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>3</Hour>
          <Minute>51</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35600275</ArticleId>
        <ArticleId IdType="pmc">PMC9116119</ArticleId>
        <ArticleId IdType="doi">10.1177/87551225221074588</ArticleId>
        <ArticleId IdType="pii">10.1177_87551225221074588</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
U.S. Food and Drug Administration. Analysis and
recommendations for agency action regarding nonsteroidal anti-inflammatory
drugs and cardiovascular risk. J Pain Palliat Care
Pharmcother.
2005;19(4):83-97.</Citation>
        </Reference>
        <Reference>
          <Citation>
Bombardier C, Laine L, Reicin A, et al.. Comparison of upper
gastrointestinal toxicity of rofecoxib and naproxen in patients with
rheumatoid arthritis. VIGOR study group. N Engl J
Med.
2000;343(21):1520-1528.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11087881</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bresalier RS, Sandler RS, Quan H, et al.. Cardiovascular events
associated with rofecoxib in a colorectal adenoma chemoprevention
trial. N Engl J Med.
2005;352(11):1092-1102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15713943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sibbald B.
Rofecoxib (Vioxx) voluntarily withdrawn from
market. CMAJ.
2004;171(9):1027-1028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC526313</ArticleId>
            <ArticleId IdType="pubmed">15505253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kulik A, Bykov K, Choudhry NK, Bateman BT.
Non-steroidal anti-inflammatory drug administration after
coronary artery bypass surgery: utilization persists despite the boxed
warning. Pharmacoepidemiol Drug Saf.
2015;24(6):647-653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25907164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Howard ML, Warhurst RD, Sheehan C.
Safety of continuous infusion ketorolac in postoperative coronary
artery bypass graft surgery patients. Pharmacy
(Basel).
2016;4(3):22.</Citation>
        </Reference>
        <Reference>
          <Citation>
Mirmohammad-Sadeghi M, Etesampour A, Gharipour M, et al.. Early chest tube removal
after coronary artery bypass graft surgery. North Am
J Med Sci.
2009;1(7):333-337.</Citation>
        </Reference>
        <Reference>
          <Citation>
Bryan AJ, Angelini GD.
Postoperative drainage and pericardial effusion.
Ann Thorac Surg.
1990;50(2):330.</Citation>
        </Reference>
        <Reference>
          <Citation>
Gereckoglu H, Aydin NB, Dagdeviren B, et al.. Effect of timing of chest
tube removal on development of pericardial effusion following cardiac
surgery. J Card Surg.
2003;18(3):217-224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12809395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
French DG, Dilena M, LaPlante S, et al.. Optimizing postoperative
care protocols in thoracic surgery: best evidence and new
technology. J Thorac Dis.
2016:8(suppl 1):
S3-S11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4756237</ArticleId>
            <ArticleId IdType="pubmed">26941968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bellomo R, Ronco C, Kellum JA, et al.. Acute renal
failure-definition, outcome measures, animal models, fluid therapy and
information technology needs: the Second International Consensus Conference
of the Acute Dialysis Quality Initiative (ADQI) Group.
Crit Care.
2004;8:R204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC522841</ArticleId>
            <ArticleId IdType="pubmed">15312219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nussmeier NA, Whelton AA, Brown MT, et al.. Complications of the COX-2
inhibitors parecoxib and valdecoxib after cardiac surgery.
N Engl J Med.
2005;352:1081-1091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15713945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hynninen MS, Cheng DCH, Hossain I, et al.. Non-steroidal
anti-inflammatory drugs in treatment of postoperative pain after cardiac
surgery. Can J Anesth.
2000;47(12):1182-1187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11132739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Engoren MC, Habib RH, Zacharias A, et al.. Postoperative analgesia with
ketorolac is associated with decreased mortality after isolated coronary
artery bypass graft surgery in patients already receiving aspirin: a
propensity-matched study. J Cardiothorac Vasc
Anesth.
2007;21(6):820-826.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18068059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Engoren M, Hadaway J, Schwann TA, Habib RH.
Ketorolac improves graft patency after coronary artery bypass
grafting: a propensity-matched analysis. Ann Thorac
Surg.
2001;92(2):603-609.</Citation>
        </Reference>
        <Reference>
          <Citation>
Oliveri L, Jerzewski K, Kulik A.
Black box warning: is ketorolac safe for use after cardiac
surgery?
J Cardiothorac Vasc Anesth.
2014;28(2):274-279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24231193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Meek IL, van de Laar MAFJ, Vonkeman HE.
Non-steroidal anti-inflammatory drugs: an overview of
cardiovascular risks. Pharmaceuticals.
2010;3(7):2146-2162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4036661</ArticleId>
            <ArticleId IdType="pubmed">27713346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
European Medicines Agency update on non-selective NSAIDs.
Published October 17, 2005. Accessed May 22, 2019. https://www.ema.europa.eu/en/news/european-medicines-agency-update-non-selective-nsaids</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
